Picture of Telix Pharmaceuticals logo

TLX — Telix Pharmaceuticals Cashflow Statement

0.000.00%
au flag iconLast trade - 00:00
HealthcareAdventurousMid CapMomentum Trap

Annual cashflow statement for Telix Pharmaceuticals, fiscal year end - December 31st, AUD millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Changes in Working Capital
Other Operating Cash Flow
Cash from Operating Activities
Capital Expenditures
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items
Acquisition of Business
Sale of Business
Other Investing Cash Flow
Cash from Investing Activities
Financing Cash Flow Items
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash

Or unlock with your email

Or unlock with your email